GRIN2A and stroke disorder: Autoantibodies to the glutamate NMDA-R (N-methyl-D aspartate receptors; NR2A/NR2B subunits) associated with neurotoxicity are elevated after stroke and distinguish IS patients (n = 31) from controls 3 h after symptoms onset with 97% sensitivity and 98% specificity (47).